Innovating to improve health worldwide

WIPO, IFPMA and Interpat join forces to support health innovation through IP management clinics

The World Intellectual Property Organization (WIPO), the International Federation of Pharmaceutical Manufacturers and Associations (IFPMA) and Interpat have launched a new partnership that underlines a shared commitment to intellectual property supporting health innovation.

Global biopharmaceutical CEOs response to reforms introduced in Germany

On 30 June, in response to reforms introduced in Germany, BCR Secretary General, and IFPMA Director General, Dr. David Reddy, said: “The legislation introduced by the German government undermines the value of medical innovation, global competitiveness and patient access to new medicines. Pricing and reimbursement policies which fail to reflect the value that medicines and...

2026 UN High-Level Meeting on HIV/AIDS

On 22 June 2026, IFPMA delivered a statement at the UN High-Level Meeting on HIV/AIDS in New York. Excellencies, distinguished delegates, I am pleased to speak on behalf of the IFPMA, representing the innovative pharmaceutical industry. As Member States gather at this High-Level Meeting to renew global commitments on HIV/AIDS, IFPMA welcomes the Political Declaration’s...